The role of cannabinoids in the treatment of cancer
L Vecera, T Gabrhelik, P Prasil, P Stourac
Key takeaways
- 01
Cannabinoids show potential for inhibiting cancer growth in lab settings, but more clinical research is required to establish their therapeutic role.
Aim: The aim of this review article is to summarize current knowledge about the role of cannabinoids and cannabinoid receptors in tumor disease modulation and to evaluate comprehensively the use of cannabinoids in cancer patients.
Method: According to the PRISMA protocol, we have included data from a total of 105 articles.
Results: Cannabinoids affect cancer progression by three mechanisms. The most important mechanism is the stimulation of autophagy and affecting the signaling pathways leading to apoptosis. The most important mechanism of this process is the accumulation of ceramide. Cannabinoids also stimulate apoptosis by mechanisms independent of autophagy. Other mechanisms by which cannabinoids affect tumor growth are inhibition of tumor angiogenesis, invasiveness, metastasis, and the modulation of the anti-tumor immune response.
Conclusion: In addition to the symptomatic therapy of cancer patients, the antitumor effects of cannabinoids (whether in monotherapy or in combination with other cancer therapies) have promising potential in the treatment of cancer patients. More clinical trials are needed to demonstrate the antitumor effect of cannabinoids (Tab. 1, Fig. 1, Ref. 167).
The episode was first published on the Swedish podcast Fasciaguiden on June 4, 2025. In this unique episode, we meet Professor Gerald Pollack — one of the world’s most influential…
Fascia research has sparked a wildfire of new insights that are challenging conventional belief about how the living body works. In the last 15-20 years thousands of high quality…